What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Cancer
His primary scientific interests are in Hepatitis B virus, Hepatocellular carcinoma, Immunology, Internal medicine and Virology.
His biological study spans a wide range of topics, including Hepatitis B, Viral load and Genotype.
Pei-Jer Chen works mostly in the field of Hepatocellular carcinoma, limiting it down to topics relating to Carcinoma and, in certain cases, Prospective cohort study, as a part of the same area of interest.
Immunology connects with themes related to Liver disease in his study.
His work deals with themes such as Gastroenterology, Ribavirin, Surgery and Oncology, which intersect with Internal medicine.
In his study, Molecular biology is strongly linked to Plasmid, which falls under the umbrella field of Virology.
His most cited work include:
- Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. (1023 citations)
- Hepatitis B e antigen and the risk of hepatocellular carcinoma. (995 citations)
- Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B (833 citations)
What are the main themes of his work throughout his whole career to date?
Pei-Jer Chen mostly deals with Virology, Hepatitis B virus, Internal medicine, Immunology and Hepatocellular carcinoma.
His Hepatitis B virus study frequently draws connections to other fields, such as Hepatitis B.
The concepts of his Hepatitis B study are interwoven with issues in Viral hepatitis and Liver disease.
Pei-Jer Chen combines subjects such as Gastroenterology, Ribavirin and Oncology with his study of Internal medicine.
His research on Immunology often connects related areas such as Genotype.
His Hepatocellular carcinoma study combines topics in areas such as Cirrhosis and Pathology.
He most often published in these fields:
- Virology (37.44%)
- Hepatitis B virus (33.38%)
- Internal medicine (32.87%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (32.87%)
- Hepatitis B virus (33.38%)
- Gastroenterology (20.56%)
In recent papers he was focusing on the following fields of study:
Pei-Jer Chen mainly focuses on Internal medicine, Hepatitis B virus, Gastroenterology, Hepatocellular carcinoma and Virology.
His Internal medicine research incorporates themes from Ribavirin and Hepatitis C virus.
His work investigates the relationship between Hepatitis C virus and topics such as Coinfection that intersect with problems in LEDIPASVIR/SOFOSBUVIR.
His Hepatitis B virus study is related to the wider topic of Immunology.
His Gastroenterology research includes themes of Interferon, HBeAg, Viral load and Confidence interval.
Pei-Jer Chen has included themes like Viral hepatitis, Hepatitis C and Oncology in his Hepatocellular carcinoma study.
Between 2016 and 2021, his most popular works were:
- Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update (636 citations)
- Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected With HBV (61 citations)
- A research agenda for curing chronic hepatitis B virus infection. (43 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- DNA
His primary areas of investigation include Internal medicine, Hepatitis B virus, Hepatitis B, Gastroenterology and Virology.
Pei-Jer Chen is interested in Hepatocellular carcinoma, which is a field of Internal medicine.
His Hepatitis B virus research is classified as research in Immunology.
The Hepatitis B study which covers Chronic hepatitis that intersects with Curing, Dna viral and Hepatitis D.
The various areas that he examines in his Gastroenterology study include Risk factor, Viral load and Hazard ratio.
His study on cccDNA, Dasabuvir and Viremia is often connected to CCL5 as part of broader study in Virology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
